These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Opioid peptides. Biological study of [D-MetO2] dermorphin analogues in relation to the plurality of opioid receptors. XI. Marastoni M; Salvadori S; Tomatis R; Borea PA; Bertelli G Farmaco Sci; 1987 Feb; 42(2):125-31. PubMed ID: 3032674 [TBL] [Abstract][Full Text] [Related]
25. Different effects of dynorphin A on in vitro guinea pig hippocampal CA3 pyramidal cells with various degrees of paired-pulse facilitation. Iwama T; Ishihara K; Satoh M; Takagi H Neurosci Lett; 1986 Jan; 63(2):190-4. PubMed ID: 2869458 [TBL] [Abstract][Full Text] [Related]
26. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H. Bot G; Chahl LA; Brent PJ; Johnston PA Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440 [TBL] [Abstract][Full Text] [Related]
27. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. Takemori AE; Ho BY; Naeseth JS; Portoghese PS J Pharmacol Exp Ther; 1988 Jul; 246(1):255-8. PubMed ID: 2839664 [TBL] [Abstract][Full Text] [Related]
28. Identification of opioid receptors on gastric muscle cells by selective receptor protection. Grider JR; Makhlouf GM Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978 [TBL] [Abstract][Full Text] [Related]
29. Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids. Ramme D; Illes P Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):57-61. PubMed ID: 2869418 [TBL] [Abstract][Full Text] [Related]
33. Differential effect of mu, delta, and kappa opioid agonists on adenylate cyclase activity. De Montis GM; Devoto P; Preti A; Tagliamonte A J Neurosci Res; 1987; 17(4):435-9. PubMed ID: 2887665 [TBL] [Abstract][Full Text] [Related]
34. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo. Sheldon RJ; Nunan L; Porreca F J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899 [TBL] [Abstract][Full Text] [Related]
35. Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice. Hong EK; Takemori AE J Pharmacol Exp Ther; 1989 Nov; 251(2):594-8. PubMed ID: 2553928 [TBL] [Abstract][Full Text] [Related]
36. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus. Garaulet JV; Laorden ML; Milanés MV J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886 [TBL] [Abstract][Full Text] [Related]
37. Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit. Jackisch R; Geppert M; Illes P J Neurochem; 1986 Jun; 46(6):1802-10. PubMed ID: 2871130 [TBL] [Abstract][Full Text] [Related]
38. Differential effects of opioid receptor agonists on nociception and cAMP level in the spinal cord of monoarthritic rats. Przewłocka B; Dziedzicka M; Lasoń W; Przewłocki R Life Sci; 1992; 50(1):45-54. PubMed ID: 1345879 [TBL] [Abstract][Full Text] [Related]
39. The peristaltic reflex in the rat ileum: evidence for functional mu- and delta-opiate receptors. Coupar IM J Pharm Pharmacol; 1995 Aug; 47(8):643-6. PubMed ID: 8583364 [TBL] [Abstract][Full Text] [Related]
40. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists. Matsumoto RR; Brinsfield KH; Patrick RL; Walker JM J Pharmacol Exp Ther; 1988 Jul; 246(1):196-203. PubMed ID: 2839661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]